Program Mounjaro: Advancing Medical Weight Management Results
Introducing Program Mounjaro (Tirzepatide), a significant advancement in the science of medical weight management. It is the world’s first and only “Dual-Action” treatment, simultaneously targeting two distinct gut hormones—GIP and GLP-1—to produce a synergistic effect. The result is a level of weight management efficacy that is truly remarkable, with clinical studies reporting a maximum average weight loss of up to 26.6% of initial body weight (individual results may vary).
At The Zenith Clinic, we are proud to be at the forefront of this medical advancement, offering this state-of-the-art program under the expert direction of Dr. Nat Saengsiriwut and our medical team.
Mechanism of Program Mounjaro
Program Mounjaro’s status as a “twincretin” is what sets it apart. By activating two hormone receptors at once, it creates a more powerful, comprehensive effect
- GLP-1 Receptor : The primary driver for appetite suppression, delayed digestion, and improved insulin response.
- GIP Receptor: Works in concert with GLP-1 to further enhance appetite control and insulin secretion, while also playing a role in improving fat metabolism.
This dual activation leads to demonstrably superior results compared to medications that target the GLP-1 pathway alone.
A New Gold Standard in Clinical Results
Data from the clinical trial program highlights the groundbreaking potential of Program Mounjaro
Highest Recorded Weight Loss
Participants on the highest dose (15 mg) achieved an average weight loss of 22.5% of their starting body weight in 72 weeks (individual results may vary).
Sustained and Enhanced Efficacy
In an extended study, participants who completed an intensive lifestyle program and continued with the medication achieved a total mean weight loss of 26.6% over 84 weeks—the highest ever recorded in an obesity medication trial (individual results may vary).
Holistic Health Improvements
Alongside dramatic weight loss, participants showed significant improvements in blood pressure, triglyceride levels, and waist circumference.
Program Zepbound in Thailand: It's Program Mounjaro at The Zenith Clinic
If your search for Program Zepbound—the brand name for Tirzepatide used for weight management in the US and Europe—has brought you here, you are in the right place. Program Mounjaro is the very same medication, containing the active ingredient Tirzepatide, officially approved for use in Thailand.
A key advantage here is that Program Mounjaro is approved for both chronic weight management (obesity) and the treatment of type 2 diabetes. This makes it an incredibly effective and versatile option for patients seeking comprehensive health and metabolic improvements.
Medication Refill Service for Expats & International Clients
For those who began their Program Mounjaro or Program Zepbound treatment abroad and require continuity of care in Thailand, The Zenith Clinic offers a superior refill service
Competitive Pricing
Access world-class treatment at a significantly more reasonable cost than in many other countries.
Expert Medical Supervision
Dr. Nat Saengsiriwut and our team will provide ongoing, close supervision to ensure your journey is safe and your results are optimized.
Convenience and Trust
Receive care at a luxurious, centrally-located Bangkok clinic with clear, professional, and trustworthy medical guidance.
Who is an Ideal Candidate for Program Mounjaro?
Program Mounjaro is an excellent option for adults who
– Are living with obesity (BMI ≥ 30) or are overweight (BMI ≥ 27) with a weight-related comorbidity.
– Are seeking the most effective weight management results available under medical supervision.
– May have not achieved their desired results with other weight management programs.
– Also have type 2 diabetes (in Thailand, Program Mounjaro is approved for both weight management and diabetes treatment).
Your Premier Mounjaro Journey at The Zenith Clinic
We ensure your treatment is safe, personalized, and effective
Physician-Led Assessment
Your journey begins with a detailed consultation with our medical team to create a tailored and safe treatment strategy.
Convenient Administration
The program requires only a simple, once-weekly self-injection with a user-friendly pen.
Dedicated Medical Oversight
Our physicians will provide continuous monitoring and support, adjusting the treatment as needed to guide you safely and effectively toward your goal.
69, 14-16 ถ. พญาไท แขวงถนนพญาไท เขตราชเทวี กรุงเทพมหานคร 10400
Social media